Hunter Associates Investment Management LLC Makes New $1.23 Million Investment in Lumexa Imaging Holdings, Inc. $LMRI

Hunter Associates Investment Management LLC purchased a new position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 142,962 shares of the company’s stock, valued at approximately $1,231,000. Hunter Associates Investment Management LLC owned about 0.15% of Lumexa Imaging as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Assetmark Inc. bought a new stake in Lumexa Imaging in the fourth quarter worth $36,000. Strs Ohio bought a new stake in shares of Lumexa Imaging during the 1st quarter worth about $38,000. Barclays PLC acquired a new position in shares of Lumexa Imaging during the 4th quarter valued at about $133,000. Sandia Investment Management LP acquired a new position in shares of Lumexa Imaging during the 4th quarter valued at about $185,000. Finally, Hudson Bay Capital Management LP bought a new position in shares of Lumexa Imaging in the 4th quarter valued at approximately $237,000.

Insiders Place Their Bets

In other Lumexa Imaging news, Director Brett Brodnax bought 35,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was purchased at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the purchase, the director directly owned 62,027 shares in the company, valued at $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.70% of the stock is currently owned by insiders.

Lumexa Imaging Stock Performance

Shares of NASDAQ:LMRI opened at $12.43 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43. The company has a 50-day simple moving average of $9.17. The firm has a market capitalization of $1.19 billion and a P/E ratio of -21.07. Lumexa Imaging Holdings, Inc. has a 52-week low of $6.45 and a 52-week high of $19.45.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Wall Street Zen raised Lumexa Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Weiss Ratings raised shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research report on Thursday, June 25th. Finally, Barclays reduced their price objective on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Lumexa Imaging presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).